Coretag, Inc.

Equities

JMKJ

US65444P2002

Advanced Medical Equipment & Technology

Market Closed - OTC Markets Other stock markets 09:54:52 2021-07-06 am EDT			5-day change	1st Jan Change
12,500 ^USD	-80.77%		-.--%	-.--%

May. 13	Coretag, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2024	CI
May. 08	Nine Alliance Science & Technology Group has Changed its Name to Coretag, Inc	CI

Coretag, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2024

May 13, 2024 at 04:31 pm EDT

Coretag, Inc. reported earnings results for the second quarter and six months ended March 31, 2024. For the second quarter, the company reported net loss was USD 0.007743 million compared to USD 0.01257 million a year ago. Basic loss per share from continuing operations was USD 0.08 compared to USD 0.13 a year ago.
For the six months, net loss was USD 0.021772 million compared to USD 0.017429 million a year ago. Basic loss per share from continuing operations was USD 0.23 compared to USD 0.19 a year ago.

Latest news about Coretag, Inc.

Coretag, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2024	May. 13	CI
Nine Alliance Science & Technology Group has Changed its Name to Coretag, Inc	May. 08	CI
Coretag, Inc. has Changed its Ticker to COTI from JMKJ	May. 08	CI
Coretag Holdings, Inc. Reports Earnings Results for the First Quarter Ended December 31, 2023	Feb. 09	CI
Nine Alliance Science & Technology Group Reports Earnings Results for the Full Year Ended September 30, 2023	Dec. 08	CI
Nine Alliance Science & Technology Group Reports Earnings Results for the Third Quarter and Nine Months Ended June 30, 2023	23-07-31	CI
Nine Alliance Science & Technology Group Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2023	23-05-12	CI
Nine Alliance Science & Technology Group Reports Earnings Results for the First Quarter Ended December 31, 2022	23-01-30	CI
Nine Alliance Science & Technology Group Reports Earnings Results for the Full Year Ended September 30, 2022	23-01-17	CI
Nine Alliance Science & Technology Group Auditor Raises 'Going Concern' Doubt	23-01-16	CI
Nine Alliance Science & Technology Group Reports Earnings Results for the Third Quarter and Nine Months Ended June 30, 2022	22-08-15	CI
Nine Alliance Science & Technology Group Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2022	22-05-10	CI
Nine Alliance Science & Technology Group Reports Earnings Results for the First Quarter Ended December 31, 2021	22-02-07	CI
Nine Alliance Science & Technology Group Reports Earnings Results for the Full Year Ended September 30, 2021	21-11-03	CI
Nine Alliance Science & Technology Group Auditor Raises 'Going Concern' Doubt	21-11-02	CI
Nine Alliance Science & Technology Group Reports Earnings Results for the Second Quarter Ended March 31, 2021	21-06-16	CI
Nine Alliance Science & Technology Group Announces Address Change	21-06-01	CI
Paramount Supply Inc. will Change its Ticker to JMKJ from PRRT	17-10-25	CI
Paramount Supply Inc. will Change its Name to Nine Alliance Science & Technology	17-10-25	CI
Paramount Supply Inc. Announces Management Changes	17-09-26	CI
Tongqing Bao acquired 80% stake in Paramount Supply Inc. from Artis Jansons.	17-05-17	CI
Nine Alliance Science & Technology Group Auditor Raises 'Going Concern' Doubt	15-12-08	CI
Paramount Supply Inc. has completed an IPO in the amount of $0.04 million.	15-09-02	CI
Nine Alliance Science & Technology Group Auditor Raises 'Going Concern' Doubt	15-07-14	CI
Paramount Supply Inc. has filed an IPO in the amount of $0.08 million.	15-02-12	CI

Chart Coretag, Inc.

Duration

Period

More charts

Company Profile

Coretag, Inc. is focused on the development of cancer imaging and targeted radiotherapy, based on its Necrosis Targeting Platform Technology (NTPT). The Company developed NTPT as a result of the discovery of a group of cyanine dyes which have selective targeting properties for intracellular proteins. These proteins become available for binding only when the cell membrane loses its integrity, which occurs once a cell has become necrotic. The Company has developed a portfolio of products that address high unmet needs in oncology. The Company develops targeted radiotherapy with 177Lu (lutetium) and 121Pb (lead) for the treatment of rapidly growing tumors and metastasis. It also develops targeted diagnostics with 89Zr (zirconium) and 111In (indium) for detecting and quantifying necrotic tissue in the human body.

Sector

Advanced Medical Equipment & Technology

More about the company

Income Statement Evolution

More financial data

Sector Medical Imaging Systems

	1st Jan change	Capi.
CORETAG, INC.	-.--%	1.12B
SHANGHAI UNITED IMAGING HEALTHCARE CO., LTD.	-24.40%	11.83B
SONOSCAPE MEDICAL CORP.	-26.83%	2.12B
IRAY TECHNOLOGY COMPANY LIMITED	-54.81%	2.11B
BEIJING WANDONG MEDICAL TECHNOLOGY CO.,LTD.	-30.04%	1.19B
GUERBET	+86.67%	491M
DETECTION TECHNOLOGY OYJ	+31.75%	286M
DRTECH CORPORATION	-15.38%	198M
VIEWORKS CO., LTD.	+2.04%	182M
INTROMEDIC CO., LTD.	-.--%	177M

Medical Imaging Systems